ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,741,987, issued on Sept. 22, was assigned to ARUMUGAVADIVEL NARENDRAN (Calgary, Canada). "Small molecule LIN28 inhibitors as anticancer agents... Read More
ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,741,988, issued on Sept. 22, was assigned to HAN YICHENG BIOLOGICAL TECHNOLOGY CO LTD. (Wuhan, China). "Method for treatment of dry eye compri... Read More
ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,741,989, issued on Sept. 22, was assigned to Entrada Therapeutics Inc. (Boston). "Compositions for delivery of antisense compounds" was invent... Read More
ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,741,990, issued on Sept. 22, was assigned to INDIAN INSTITUTE OF SCIENCE (Kamataka, India). "Peptide for disassembly of protein aggregates and... Read More
ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,741,991, issued on Sept. 22, was assigned to KATHOLIEKE UNIVERSITEIT LEUVEN (Leuven, Belgium). "Live-attenuated flaviviruses with heterologous... Read More
ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,741,992, issued on Sept. 22, was assigned to Roche Diagnostics Operations Inc. (Indianapolis). "Bacterial pilus protein complex FIMGT-DSF stab... Read More
ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,741,993, issued on Sept. 22, was assigned to DANISCO US INC. (Palo Alto, Calif.). "Methods and compositions for producing proteins of interest... Read More
ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,741,994, issued on Sept. 22, was assigned to KYOTO PREFECTURAL PUBLIC UNIVERSITY Corp. (Kyoto, Japan) and KYOTO SANGYO UNIVERSITY (Kyoto, Japan... Read More
ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,741,995, issued on Sept. 22, was assigned to Integrated DNA Technologies Inc. (Coralville, Iowa). "Ubiquitin variant with high affinity for bi... Read More
ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,741,996, issued on Sept. 22, was assigned to The Regents of the University of California (Oakland, Calif.). "Modulation of Wnt5a to treat glau... Read More